Japan and South Korea are part of a complex and tightly linked supply chain that produces electronic goods such as smartphones and laptops.Technologyread more
A different oil pricing dynamic has been evolving with new supply calculations based on the U.S. as the world's largest producer.Market Insiderread more
The Massachusetts senator's alarm-sounding on consumer debt neglects to measure it against the growth in the economy and the ability to pay.Economyread more
Stocks in Asia Pacific edged up on Tuesday morning following overnight gains on Wall Street as the earnings season rolls on.Asia Marketsread more
More than half of Venezuela's 23 states lost power on Monday, according to Reuters witnesses and reports on social media, a blackout the government blamed on an...World Politicsread more
Equifax will give consumers a range of options for monitoring their credit or making claims of fraud or data misuse, part of a $425 million restitution fund.Technologyread more
The deal between the White House and Democrats was earlier expected to raise the debt ceiling for two years and permanently end the sequester.Politicsread more
Britain's Antstream is jumping into the cloud gaming battle with a streaming platform for retro titles. And Tencent just backed the company.Technologyread more
American comedian Hannibal Buress, who stars in "The Eric Andre Show," has made a recent transition into the world of business as an angel investor — but there's an important...How I Made Itread more
The deal could be announced as soon as next week, according to the report.Technologyread more
President Donald Trump held "constructive" discussions on a range of economic issues including trade and national security issues.Technologyread more
Use of prescription opioids such as OxyContin or Vicodin fell at a record rate last year as the U.S. government cracks down on pharmacists and drugmakers that dispense the sometimes lethal painkillers, according to a report published Thursday.
Prescription opioid use in the U.S. was down 17% in 2018, marking the largest annual decline ever recorded, research firm IQVIA Institute for Human Data Science said. In 1992, prescription opioid use was at roughly 22 pain pills per U.S. adult per year and rose to a peak level of 72 pills per U.S. adult in 2011, IQVIA said. Since 2011, use has declined by 43% to 34 pills per adult.
The new data, unveiled in IQVIA's 2019 report on health-care trends, provides some hope for combating the nationwide opioid epidemic, which kills roughly 130 Americans every day. Just last month, a new study provided troubling news that the opioid crisis has led to a sharp increase in the death rate for overdoses by teens and young adults.
The Justice Department and U.S. lawmakers have been working to combat the epidemic, such as limiting painkiller prescriptions and punishing those seen as responsible for the epidemic.
On Wednesday, Sen. Elizabeth Warren, D-Mass., and House Oversight Committee Chairman Elijah Cummings, D-Md., unveiled a $100 billion proposal that would fund prevention services and provide resources to programs for those battling addiction and in recovery.
Last month, a former CEO of Rochester Drug Cooperative, one of the nation's largest drug distributors, was indicted on what prosecutors say are the first criminal charges against an executive of a drug company to stem from the opioid epidemic. In addition, the federal government reached a $20 million settlement with the company over its alleged role in the crisis.
Separately, federal prosecutors charged 60 doctors, pharmacists and other licensed medical professionals across five states in connection with illegally prescribing more than 32 million pain pills.
The indictments came as some 1,600 cases against OxyContin-maker Purdue Pharma and other opioid manufacturers are being consolidated and transferred before a judge in the Northern District of Ohio, and New York and other states begin their own massive legal fights.
The report Thursday showed prescriptions for lower-dose opioids remained stable, possibly because such painkillers are still perceived by physicians and patients as relatively safe, IQVIA said.
—CNBC's Meg Tirrell contributed to this report.
For more on investing in health-care innovation, click here to join CNBC at our Healthy Returns Summit in New York City on May 21.